Related Experiment Videos
Hysteroscopic myomectomy.
Neelam Batra1, Athele Khunda, Peter J O'Donovan
1Department of Obstetrics and Gynaecology Bradford Royal Infirmary, Duckworth Lane, Bradford BD9 6RJ, UK.
Obstetrics and Gynecology Clinics of North America
|September 29, 2004
Summary
Hysteroscopic myomectomy offers a minimally invasive approach to treating uterine fibroids, improving menstrual patterns, fertility, and patient satisfaction with a rapid recovery. This technique is recommended as a first-line conservative surgical option for symptomatic intracavitary fibroids.
Area of Science:
- Minimally Invasive Gynecological Surgery
- Reproductive Medicine
- Surgical Oncology
Background:
- Abdominal myomectomy, while effective, is associated with significant morbidity.
- Intracavitary uterine fibroids (leiomyomas) can cause abnormal uterine bleeding, infertility, and pelvic pain.
- Minimally invasive surgical options are sought to reduce patient recovery time and complications.
Purpose of the Study:
- To evaluate hysteroscopic myomectomy as a conservative surgical management for symptomatic intracavitary fibroids.
- To assess the benefits of hysteroscopic myomectomy regarding patient outcomes and recovery.
- To establish hysteroscopic myomectomy as a first-line treatment option.
Main Methods:
- Hysteroscopic myomectomy performed as an outpatient or short-stay procedure.
- Focus on appropriate case selection and surgical expertise.
- Minimally invasive approach avoiding laparotomy.
Main Results:
- Significant improvement in menstrual patterns observed.
- Positive impact on fertility rates reported.
- High overall patient satisfaction and rapid return to full activity (within 48 hours) noted.
Conclusions:
- Hysteroscopic myomectomy is a safe and effective minimally invasive treatment for symptomatic intracavitary fibroids.
- The procedure is associated with lower morbidity compared to abdominal myomectomy.
- It should be considered the primary conservative surgical therapy for suitable candidates.